As the inhibition of IL-1β signaling is important for the treatment of chronic inflammatory diseases, such as osteoarthritis and rheumatoid arthritis [25,26], the Type 3 DPIE derivative could be a good framework for anti-inflammatory agents. The gene discussed is IL1B; the disease is rheumatoid arthritis.